_dr-jos-baselga-discusses-the-everolimus-side-effect-profile-preview-1.jpg "Dr. José Baselga Discusses the Everolimus Side Effect Profile from everolimus chemotherapy Video Screenshot Preview 1")
Gallery_dr-jos-baselga-discusses-the-everolimus-side-effect-profile-preview-3.jpg "Dr. José Baselga Discusses the Everolimus Side Effect Profile from everolimus chemotherapy Video Screenshot Preview 3")
Gallery_dr-jos-baselga-discusses-the-everolimus-side-effect-profile-preview-hqdefault.jpg "Dr. José Baselga Discusses the Everolimus Side Effect Profile from everolimus chemotherapy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 13 seconds
👁 View: 998 times
Play Audio:👁 View: 998 times
Description:
Targeted Oncology
Targeted Oncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_integration-of-radiotherapy-in-muscle-invasive-bladder-cancer.webp "UBC Urology Rounds")
_winship-grand-rounds-july-19-2017-mehmet-asim-bilen-md.webp "Winship Cancer Institute of Emory University")
_results-from-the-geparquinto-trial.webp "Dr Huober discusses findings from the GeparQuinto study at SABCS 2011. The oral signal transduction inhibitor, everolimus, binds selectively to mTOR, an intracellular protein kinase implicated in the control of cellular proliferation of activated T-lymphocytes and neoplastic cells. Data suggested that everolimus can enhance the clinical efficacy of endocrine treatment in the metastatic and neoadjuvant setting.nnThe GeparQuinto phase III study had 3 settings: HER2-positive: trastuzumab vs lapat")
_everolimus-zortress-prescription-medication-instructions-for-post-transplant-patients.webp "Barnes-Jewish Hospital")
⏲ 3 minutes 30 seconds 👁 607
_update-11-neuroendocrine-tumors.webp "HMP Education")
_real-world-efficacy-of-everolimus-exemestane-hr-her2-bc.webp "VJOncology")
_dr-james-yao-on-everolimus-in-advanced-pancreatic-neuroendocrine-tumors.webp "OncLiveTV")
_dr-jos-baselga-discusses-the-everolimus-side-effect-profile.webp "Targeted Oncology")
_integration-of-radiotherapy-in-muscle-invasive-bladder-cancer.jpg)
_winship-grand-rounds-july-19-2017-mehmet-asim-bilen-md.jpg)
_results-from-the-geparquinto-trial.jpg)
_everolimus-zortress-prescription-medication-instructions-for-post-transplant-patients.jpg)
_update-11-neuroendocrine-tumors.jpg)
_real-world-efficacy-of-everolimus-exemestane-hr-her2-bc.jpg)
_dr-james-yao-on-everolimus-in-advanced-pancreatic-neuroendocrine-tumors.jpg)
_dr-jos-baselga-discusses-the-everolimus-side-effect-profile.jpg)
![[+]](/images/menu.gif){kind=small}